Literature DB >> 1680918

Characterization of the human Ig V lambda II gene family and analysis of V lambda II and C lambda polymorphism in systemic lupus erythematosus.

E Paul1, A Livneh, A J Manheimer-Lory, B Diamond.   

Abstract

We report the cDNA sequence of an expressed human V lambda II gene and present an RFLP analysis of the Ig gene family defined by this clone. This V lambda II gene was expressed in a monoclonal B cell line generated from a patient with SLE by transformation with EBV. The encoded lambda L chain displays the 8.12 Id, an Id common to anti-DNA antibodies from patients with SLE. Using a coding region probe we estimate from Southern blot analysis that the germline V lambda II gene family contains at least 15 members. Many of the V lambda II restriction fragments are polymorphic both in SLE patients and in nonautoimmune individuals. EcoRI, HindIII, and TaqI RFLP analyses of the V lambda II gene family and EcoRI analysis of the C lambda gene family reveal no polymorphisms specific to SLE. Observed V lambda II and C lambda allele frequencies are the same among SLE patients and nonautoimmune individuals, and show no evidence of linkage disequilibrium between the two loci.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

2.  Molecular analysis of the human immunoglobulin V lambda II gene family.

Authors:  M Irigoyen; A Manheimer-Lory; B Gaynor; B Diamond
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

3.  Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment.

Authors:  L C Jefferies; C M Carchidi; L E Silberstein
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

4.  Structure of the VH and VL segments of polyreactive and monoreactive human natural antibodies to HIV-1 and Escherichia coli beta-galactosidase.

Authors:  N Harindranath; H Ikematsu; A L Notkins; P Casali
Journal:  Int Immunol       Date:  1993-12       Impact factor: 4.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.